NFL Biosciences SA (EPA:ALNFL)
France · Delayed Price · Currency is EUR 1.296
-0.016 (-1.22%)
Oct 6, 2025, 5:24 PM CET
NFL Biosciences Market Cap
NFL Biosciences has a market cap or net worth of €16.63 million as of October 6, 2025. Its market cap has decreased by -9.55% in one year.
Market Cap
16.63M
Enterprise Value
14.55M
Revenue
46.00
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.30
Market Cap Chart
Since July 5, 2021, NFL Biosciences's market cap has decreased from 19.47M to 16.63M, a decrease of -14.62%. That is a compound annual growth rate of -3.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 16.63M | -13.04% |
| Dec 31, 2024 | 19.12M | 63.78% |
| Dec 29, 2023 | 11.67M | 13.49% |
| Dec 30, 2022 | 10.29M | -18.13% |
| Dec 31, 2021 | 12.56M | -35.48% |
| Jul 5, 2021 | 19.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 130.41B |
| Sanofi | 105.62B |
| Sartorius Stedim Biotech | 19.32B |
| bioMérieux | 13.77B |
| Eurofins Scientific SE | 11.16B |
| Ipsen | 9.56B |
| ABIVAX Société Anonyme | 5.46B |
| Virbac | 2.71B |